Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $822.6600 (-0.95%) ($822.6600 - $822.6600) on Wed. Nov. 8, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.14% (three month average) | RSI | 54 | Latest Price | $822.6600(-0.95%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN advances 0.8% a day on average for past five trading days. | Weekly Trend | REGN advances 1.6% a week on average for past two weeks. | Market Behavior | Normal for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) XLV(59%) IBB(50%) SPY(46%) SDY(45%) SPLV(45%) | Factors Impacting REGN price | REGN will decline at least -0.57% in a week (0% probabilities). VXX(-42%) VIXM(-27%) TBT(-20%) UNG(-16%) SKYY(-7%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.57% (StdDev 1.14%) | Hourly BBV | -1.1 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $824.2(-0.19%) | 10 Day Moving Average | $804.7(2.23%) | 20 Day Moving Average | $811.1(1.43%) | To recent high | -2.7% | To recent low | 6.1% | Market Cap | $87.226b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |